Add on Metformin can offset weight gain due to medicines for bipolar disorder Written By Dr. Kamal Kant Kohli25 Jan 2024 10:00 AM ISTA new large-scale study led by researchers at the University of Cincinnati and Northwell Health, New York's largest health care provider, found the...
Evergreen Talk Series: Position paper published in JAPI indicated that Linagliptin is simplifying T2DM management in a Wide Range of Patients Written By Dr. Brij Mohan Makkar23 Jan 2024 11:30 AM ISTPresenting the Evergreen Talk Series featuring Dr. Brij Mohan Makkar, a Senior Diabetologist and Obesity Specialist from Delhi, Dr Sameer I. Dani, an...
Metformin paired with cimetidine may raise risk of lactic acidosis in patients with renal failure: Study Written By Medha Baranwal11 Jan 2024 7:00 PM ISTChina: Metformin combined with cimetidine may raise the risk of lactic acidosis (LA) in patients with mild-to-moderate renal failure (RF), a recent...
Higher AMH levels lower ovulation chances during induction with clomiphene and metformin in PCOS patients Written By Medha Baranwal5 Jan 2024 10:15 PM ISTUSA: A recent study published in Fertility and Sterility has shown reduced odds of ovulation with ovulation induction (OI) with clomiphene, metformin,...
Evergreen Talk Series: Clinical Considerations for Linagliptin and its combinations with Metformin, Dapagliflozin Written By Dr. Brij Mohan Makkar2 Jan 2024 11:00 AM ISTPresenting the Evergreen Talk Series featuring Dr. Brij Mohan Makkar, a Senior Diabetologist and Obesity Specialist from Delhi, Dr Sameer I. Dani,...
Lupin Launches Dapaturn GM Range for Improved Approach to Manage Type 2 Diabetes Written By Dr. Nandita Mohan1 Jan 2024 11:45 AM ISTGlobal pharma major Lupin Limited announced the launch of Dapaturn GM Forte for the treatment of diabetic patients in India. Lupin's Dapaturn GMâ„¢...
Modify eGFR value as per standard guidelines: CDSCO Panel Tells Hetero Lab on Antidiabetic FDC Drug Written By Dr. Divya Colin31 Dec 2023 5:15 PM ISTNew Delhi: Reviewing the drug major Hetero Lab's revised Phase III clinical trial protocol of fixed-dose combination antidiabetic drug Sitagliptin...
Metformin and SGLT2 inhibitor combo may increase survival in diabetes patients with cirrhosis Written By Medha Baranwal29 Dec 2023 2:00 AM ISTUSA: Dual treatment with metformin and SGLT2 inhibitor reduced hepatic complications and improved survival in type 2 diabetes (T2D) patients with...
Synokem Pharmaceutical Gets CDSCO Panel Nod To study Antidiabetic FDC Drug Written By Dr. Divya Colin21 Dec 2023 6:00 PM ISTNew Delhi: With the condition of including more government sites distributed geographically, Synokem Pharmaceutical has got approval from the Subject...
Evergreen Talk Series: Linagliptin and Dapagliflozin combination for T2DM with Cardiovascular risk or established ASCVD Written By Dr. Brij Mohan Makkar21 Dec 2023 11:45 AM ISTPresenting the Evergreen Talk Series featuring Dr. Brij Mohan Makkar, a Senior Diabetologist and Obesity Specialist from Delhi, Dr. Sameer I. Dani,...
Initiation of noninsulin second-line Antidiabetics fraught with risk of discontinuation within one year: Study Written By Dr. Kamal Kant Kohli18 Dec 2023 12:30 AM ISTUSA: Adherence to second-line diabetes drugs can be hit or miss among patients with type 2 diabetes, a recent study has reported.The findings...
Modify phase III clinical trial protocol: CDSCO panel tells Akum Pharma on antidiabetic FDCÂ Dr. Divya Colin17 Dec 2023 5:30 PM ISTNew Delhi: Approving to conduct the bioequivalence (BE) study of the antidiabetic drug combination Repaglinide plus Voglibose plus Metformin...
